α1-Antichymotrypsin activity correlates with and may modulate matrix metalloproteinase-9 in human acute wounds

Wound Repair and Regeneration

Volumn 17, Issue 3, 2009, Pages 418-426

  Reiss, Matthew J ^b   Han, Yuan Ping ^b   Garner, Warren L ^a,b  

^a 5M/5D Burn Center ^*  (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; GELATINASE B; ALPHA 1 ANTITRYPSIN;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLISTER; BURN PATIENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TISSUE CULTURE; WOUND HEALING; ZYMOGRAPHY; ADOLESCENT; BIOPSY; BIOSYNTHESIS; BURN; CELL CULTURE; COMPARATIVE STUDY; INJURY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SKIN; WESTERN BLOTTING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALPHA 1-ANTITRYPSIN; BIOPSY; BLOTTING, WESTERN; BURNS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; HUMANS; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; SKIN; WOUND HEALING; YOUNG ADULT;

EID: 65949102554     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2009.00476.x     Document Type: Article

References (40)

1. Heit JA, Rooke TW, Silverstein MD, Mohr DN, Lohse CM, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg 2001 33 : 1022 7. (Pubitemid 33586346)
2. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005 293 : 217 28. (Pubitemid 40095873)
3. Kaomongkolgit R, Cheepsunthorn P, Pavasant P, Sanchavanakit N. Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells. Oral Oncol 2008 44 : 587 94.
4. Yuecheng Y, Xiaoyan X. Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2. Eur J Cancer Prev 2007 16 : 430 5. (Pubitemid 47550003)
5. Tang CH, Tan TW, Fu WM, Yang RS. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis 2008 29 : 35 43.
6. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Konttinen YT. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 1996 106 : 1119 24. (Pubitemid 26155102)
7. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993 101 : 64 8. (Pubitemid 23213014)
8. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996 107 : 743 8. (Pubitemid 26371092)
9. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999 7 : 442 52. (Pubitemid 30027566)
10. Vaalamo M, Weckroth M, Puolakkainen P, Kere J, Saarinen P, Lauharanta J, Saarialho-Kere UK. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 1996 135 : 52 9. (Pubitemid 26225115)
11. Young PK, Grinnell F. Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J Invest Dermatol 1994 103 : 660 4. (Pubitemid 24350132)
12. Dasu MR, Spies M, Barrow RE, Herndon DN. Matrix metalloproteinases and their tissue inhibitors in severely burned children. Wound Repair Regen 2003 11 : 177 80. (Pubitemid 36648875)
13. Han YP, Nien YD, Garner WL. Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase. J Biol Chem 2002 277 : 27319 27.
14. Daniels JT, Geerling G, Alexander RA, Murphy G, Khaw PT, Saarialho-Kere U. Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Exp Eye Res 2003 77 : 653 64. (Pubitemid 37373579)
15. Saarialho-Kere UK. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 1998 290 (Suppl.) : S47 54. (Pubitemid 28502520)
16. Ashcroft GS, Herrick SE, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J Pathol 1997 183 : 169 76. (Pubitemid 27436020)
17. Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem 1980 255 : 3931 4.
18. Krischek B, Akagawa H, Tajima A, Narita A, Kasuya H, Hori T, Inoue I. The alanine/threonine polymorphism of the alpha-1-antichymotrypsin (SERPINA3) gene and ruptured intracranial aneurysms in the Japanese population. Cerebrovasc Dis 2007 23 : 46 9. (Pubitemid 46112801)
19. Kainulainen V, Wang H, Schick C, Bernfield M. Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J Biol Chem 1998 273 : 11563 9. (Pubitemid 28272053)
20. Travis J. Structure, function, and control of neutrophil proteinases. Am J Med 1988 84 (6A) : 37 42. (Pubitemid 18161673)
21. Takagi M, Konttinen YT, Santavirta S, Kangaspunta P, Suda A, Rokkanen P. Cathepsin G and alpha 1-antichymotrypsin in the local host reaction to loosening of total hip prostheses. J Bone Joint Surg Am 1995 77 : 16 25.
22. Schmidt R. Topical delivery of alpha1 - antichymotrypsin for wound healing. Munchen : Ludwig-Maximilians-Universitat, 2005.
23. Han YP, Yan C, Garner WL. Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1- antichymotrypsin. J Invest Dermatol 2008 128 : 2334 42.
24. Stricklin GP, Li L, Nanney LB. Localization of mRNAs representing interstitial collagenase, 72-kda gelatinase, and TIMP in healing porcine burn wounds. J Invest Dermatol 1994 103 : 352 8. (Pubitemid 24329756)
25. Stricklin GP, Li L, Jancic V, Wenczak BA, Nanney LB. Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol 1993 143 : 1657 66. (Pubitemid 24058269)
26. Margolis DJ, Bartus C, Hoffstad O, Malay S, Berlin JA. Effectiveness of recombinant human platelet-derived growth factor for the treatment of diabetic neuropathic foot ulcers. Wound Repair Regen 2005 13 : 531 6. (Pubitemid 43934520)
27. Agren MS, Mirastschijski U, Karlsmark T, Saarialho-Kere UK. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp Dermatol 2001 10 : 337 48. (Pubitemid 32916283)
28. Moses MA. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 1997 15 : 180 9. (Pubitemid 27225283)
29. Colnot DR, Roos JC, de Bree R, Wilhelm AJ, Kummer JA, Hanft G, Heider KH, Stehle G, Snow GB, van Dongen GA. Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 2003 52 : 576 82. (Pubitemid 37056133)
30. Scott KA, Arnott CH, Robinson SC, Moore RJ, Thompson RG, Marshall JF, Balkwill FR. TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration? Oncogene 2004 23 : 6954 66. (Pubitemid 39279996)
31. Ashcroft GS, Horan MA, Ferguson MW. Aging is associated with reduced deposition of specific extracellular matrix components, an upregulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model. J Invest Dermatol 1997 108 : 430 7. (Pubitemid 27148277)
32. Ulrich D, Lichtenegger F, Unglaub F, Smeets R, Pallua N. Effect of chronic wound exudates and MMP-2/-9 inhibitor on angiogenesis in vitro. Plast Reconstr Surg 2005 116 : 539 45. (Pubitemid 41077210)
33. Lindsey ML, Escobar GP, Dobrucki LW, Goshorn DK, Bouges S, Mingoia JT, McClister DM Jr., Su H, Gannon J, MacGillivray C, Lee RT, Sinusas AJ, Spinale FG. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Heart Circ Physiol 2006 290 : H232 9.
34. Liu Z, Li N, Diaz LA, Shipley M, Senior RM, Werb Z. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J Clin Invest 2005 115 : 879 87. (Pubitemid 40489392)
35. Han YP, Tuan TL, Hughes M, Wu H, Garner WL. Transforming growth factor-beta - and tumor necrosis factor-alpha - mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem 2001 276 : 22341 50. (Pubitemid 37410907)
36. Stricklin GP, Nanney LB. Immunolocalization of collagenase and TIMP in healing human burn wounds. J Invest Dermatol 1994 103 : 488 92. (Pubitemid 24314833)
37. Fieguth A, Kleemann WJ, Troger HD. Immunohistochemical examination of skin wounds with antibodies against alpha-1-antichymotrypsin, alpha-2-macroglobulin and lysozyme. Int J Legal Med 1994 107 : 29 33. (Pubitemid 24274500)
38. Rao CN, Ladin DA, Liu YY, Chilukuri K, Hou ZZ, Woodley DT. Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol 1995 105 : 572 8.
39. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). J Neurosci 1996 16 : 7910 9. (Pubitemid 26405054)
40. Potter H, Wefes IM, Nilsson LN. The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation. Neurobiol Aging 2001 22 : 923 30. (Pubitemid 34066560)